Exelon Surges on Transmission Win, Eyes Growth Now

Introduction

Exelon (EXC) captured investor attention this week as concrete regulatory and operational developments reinforced its regulated-growth story. A PJM approval for a large high-voltage transmission line and better-than-expected fourth-quarter 2025 results combined to provide upward momentum, even as political scrutiny over rising customer bills and a bold capital plan create visible near-term risk. Below is a concise, data-driven look at the factors driving EXC’s price action and what they mean for shareholders.

What Moved the Stock This Week

Transmission project approval provides tangible upside

On February 13, Exelon shares rose after PJM approved a roughly 220-mile, 765-kV transmission corridor co-developed with NextEra Energy Transmission. High-capacity lines like this act as arterial highways for electricity—reducing congestion, improving reliability, and often qualifying for regulated returns that translate into predictable cash flows for owners. For Exelon, participation in such a project strengthens its utility earnings base and signals access to stable, rate-regulated returns over decades.

Quarterly results and guidance reinforced momentum

Exelon’s Q4/2025 release beat expectations on adjusted operating EPS (reported at $0.59 for the quarter) and delivered full-year adjusted EPS of $2.77, up from $2.50 the prior year. Management set 2026 guidance between $2.81 and $2.91 (midpoint $2.86), and unveiled an ambitious four-year capital program totaling about $41.3 billion aimed at roughly 7.9% rate-base growth. The combination of an earnings beat and an aggressive CAPEX plan is a typical driver for utilities’ valuations because it projects higher regulated asset growth and, ultimately, higher authorized returns on an expanding rate base.

Balancing Growth with Affordability Pressures

Record capacity prices and customer pain

While the CAPEX push and transmission wins are growth-positive, Exelon is navigating headwinds from soaring capacity prices in PJM—recent figures reached around $333 per megawatt-day—contributing to larger consumer bills. That dynamic has elevated political and regulatory scrutiny in key states where Exelon operates, including Illinois, Maryland, and Pennsylvania.

Company response and regulatory pivots

To temper backlash, Exelon rolled out roughly $60 million in customer-relief measures, including a $10 million contribution announced in January. Separately, the company is pursuing a potentially transformative policy change in Maryland that would reverse long-standing deregulation and allow it to re-enter power generation under rate-regulated recovery. That initiative is high‑impact and binary in nature: success could unlock a new, regulated earnings stream; failure could leave Exelon exposed to continued merchant risk and political friction.

Near-Term Financial Drivers and Rate Actions

Several pending and recently approved rate actions across Exelon’s utilities underpin the company’s forward growth model. Specific near-term uplifts include approximately $243 million at ComEd, about $77 million at BGE through under-collection recovery, an estimated $54 million at Atlantic City Electric, and filings/approvals in DPL for both electric and natural gas increases (roughly $45 million filed electric, $22 million approved gas). These ratemaking outcomes materially affect the company’s regulated earnings trajectory in 2026 and beyond.

Stock Movement Snapshot

Exelon’s share price reflected the tug-of-war between positive execution and political risk. On February 13 the stock climbed about 1.96% to roughly $48.48—nearly matching its 52-week high—following the transmission approval and earnings. By February 18 shares had pulled back to around $47.24 amid continued investor caution about affordability headwinds and legislative uncertainty. Volume patterns during the week were elevated versus longer-term averages, signaling active repositioning by market participants.

Investor Takeaways

• Near-term upside stems from regulated transmission wins and a large CAPEX pipeline that should expand the regulated rate base and support earnings growth.
• Regulatory outcomes are binary and material: success in Maryland and constructive rate case rulings will validate the growth thesis; sustained affordability backlash or unfavorable legislation could compress returns and political goodwill.
• Operational wins like the PJM-approved 765-kV line are tangible catalysts that translate into multi-decade cash flow visibility—valuable for a utility—but they must be balanced against short-term political sensitivity to rising customer bills.

Conclusion

Exelon’s recent week showcased the hallmarks of a regulated-utility growth story: concrete infrastructure approvals, an earnings beat, and a large CAPEX program that points to durable rate-base expansion. At the same time, record capacity prices and an active push to change Maryland’s regulatory posture introduce headline risk that can quickly move sentiment. For investors, the next meaningful milestones will be Maryland’s legislative developments, the progress of rate cases across Exelon’s utilities, and further project approvals tied to the company’s CAPEX roadmap.